JSTL logo

Jeevan Scientific Technology Ltd

JSTL·BSE·
₹88.50▼ -0.02 (-0.02%)
Market Cap176.52 Cr
PE Ratio170.19
Volume18,079
Day High - Low89.80 - 87.05
52W High-Low93.90 - 57.15

Jeevan Scientific Technology Ltd (JSTL): company summary

The company's annual revenue rose 31.4% year-over-year, while annual net profit surged 1616.7% to ₹1 crore.

Jeevan Scientific Technology Ltd (JSTL) is a micro-cap Healthcare company valued at ₹177 crore operating in Healthcare Technology on the NSE and BSE.

Recent price move
Jeevan Scientific Technology Ltd last traded at ₹88.5, modestly down 0.02% on the day.
Recent developments
On 2026-09-30, the promoter holding decreased by 0.25 percentage points to 30.00%. In the latest quarter, the company reported a net profit of ₹1 crore, reversing a net loss of ₹3 crore in the same quarter a year earlier.
Financial performance
The company's annual revenue rose 31.4% year-over-year, while annual net profit surged 1616.7% to ₹1 crore. The latest quarter saw revenue jump 107.7% compared to the same quarter a year earlier, and net profit swung from a net loss of ₹3 crore to a profit of ₹1 crore.
Valuation multiples
The stock trades at 170.2 times earnings, a premium to the Healthcare median of 32.0, 2.27 times book value. It yields 1.5%.
Things to watch
The stock is 5.7% below its 52-week high. Net profit margin increased 1.6 percentage points to 1.7%, but return on equity remains low at 1.4%. The company's profit over the past five years has declined at a rate of -38.5% annually.
Where it stands
The company's latest quarter showed a significant turnaround, with net profit turning from a loss to a profit. The stock is currently 5.7% below its 52-week high, and the promoter holding has slightly decreased.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
2.7/10
Poor
Fair Value
Sign in to see
ROE
1.44%
Weak
P/E
170.19x
Expensive
Debt / Equity
0.24
Low
Industry
Healthcare
Healthcare Technology
Overall View
Mixed

Price performance

Day₹87.05
₹89.80
52W₹57.15
₹93.90
DocStoX take

Supported by momentum (7.5), but held back by valuation (0.0). Momentum looks strong at 7.5, but that is offset by valuation at 0.0 and growth at 0.9 and quality at 2.7. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
2.7
/10
Poor
Quality
Weak
ROE 1.4%
Valuation
Expensive
P/E 170.2×
Growth
Flat
Revenue +5.6% 5Y CAGR
Risk
Moderate
D/E 0.24
Momentum
Strong
85% of 52-week range

At a glance

Market Cap
₹177 Cr
52W High / Low
₹94 / ₹57
Dividend Yield
1.47%
Promoter Holding
30.00%
EPS (TTM)
₹0.52
Book Value
₹36.12

Key highlights

  • Low leverage — D/E 0.24
  • Profit shrinking 39% a year
  • Loss-making in some of the last 5 years
1 Positive4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Technology

Jeevan Scientific Technology Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.